Subgroup analysis on the basis of these cutoff values revealed statistically significant differences in tumor location, anemia status, degree of tumor differentiation, ECOG score, and efficacy of radiation therapy between the groups with low and high N/CD4 and N/CD8 ratios, confirming the practical value of these biomarkers in clinical settings. Here, CD4 is linked to anemia (phenotype).